Instillation of Gemcitabine in Patients With Superficial Bladder Cancer
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled Phase 3 multicenter study to assess the
efficacy and safety of intravesical instillation of gemcitabine versus placebo immediately
after transurethral resection of the bladder tumor.